UK markets closed

Aurobindo Pharma Limited (AUROPHARMA.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
1,087.10-27.80 (-2.49%)
At close: 03:52PM IST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
275,912,500
246,171,300
233,665,500
245,579,400
Cost of revenue
130,794,300
118,997,000
108,151,800
106,110,800
Gross profit
145,118,200
127,174,300
125,513,700
139,468,600
Operating expenses
Research development
-
395,100
652,400
688,100
Selling general and administrative
-
23,481,700
21,770,200
24,297,200
Total operating expenses
108,426,700
101,798,300
92,511,000
94,704,500
Operating income or loss
36,691,500
25,376,000
33,002,700
44,764,100
Interest expense
2,443,500
1,289,500
368,400
595,700
Income before tax
38,801,500
26,125,000
33,727,400
73,435,900
Income tax expense
11,126,200
6,848,500
7,256,300
20,097,700
Income from continuing operations
27,675,300
19,276,500
26,471,100
53,338,200
Net income
27,704,900
19,275,000
26,481,500
53,348,400
Net income available to common shareholders
27,704,900
19,275,000
26,481,500
53,348,300
Basic EPS
39.60
32.90
45.19
91.05
Diluted EPS
39.60
32.90
45.19
91.05
Basic average shares
587,116
585,939
585,939
585,939
Diluted average shares
587,116
585,939
585,939
585,939